
One agent.
Real-world impact.
K Pro, the AI agent for biology, powered by multimodal patient data, for smarter biopharma decision making.
It continuously learns from real-world data, user feedback, and clinical validation. The first agent to connect research to care.
Intelligent orchestration of specialized AI skills
K Pro uses a single intelligent orchestrator that dynamically selects and combines specialized AI skills to solve your challenges across drug discovery and development. Instead of juggling multiple tools, you work with one agent that knows exactly which capabilities to activate.
Research-to-care intelligence
AI insights validated by real patients, connecting discovery to clinical reality
- Connects insights across the entire drug development journey, from target discovery to clinical validation
- AI reality check through unique integration with Owkin's patient validation hub
Powered by multimodal patient data
From real multimodal patient data to real world impact
- MOSAIC spatial & multiomics dataset (2700 cancer samples, 11 tumor types)
- World-largest patient data network (104 hospitals)
- Ability to integrate your own data
Learn about our patient data network
Secure, interpretable platform
Deploy confidently: compliant, transparent, and built to connect
- Deploy on your infrastructure with ISO27001, GDPR compliance
- Intelligent orchestration: builds tools and runs analyses, not just retrieval
- Connect your own agents, data, and tools via skills framework and MCP integration
K Pro Documentation
A growing library of expert-grade AI skills
Validated, customizable AI skills built from a decade of biomedical research and world-class domain expertise
- Owkin-certified skills powered by 10 yrs of biomedical AI research
- KOL-inspired skills capturing the methodology of leading domain experts
- Code your own validated analytical workflows into custom reproducible skills
Interoperable orchestration of expert AI model
One intelligent agent that knows which tools to activate at every step of discovery
- Work with one agent that knows exactly which capabilities to activate
- Cutting-edge AI tools and models
e.g. Pathology Explorer & OwkinZero - Launch parallel campaigns to uncover breakthroughs from multiple approaches
Example Use Cases
Discover how K Pro powers smarter pipeline decisions
K Pro's flexible architecture means it can tackle your specific challenges, even ones we haven't anticipated yet.

Features
FREE
Explore and demo on public data
Professional
+ K Pro Free
Decision-grade analysis on proprietary data
Data access
19 public datasets
MOSAIC subset (60 samples)
MOSAIC subset (60 samples)
Data upload
Usage
Limited
High
Privacy
Logged activity
Untracked usage
Support
Standard
Dedicated onboarding & Account Manager
Deployment
SaaS access only
Trusted by top biopharma and researchers

“The potential impact for research teams is obvious, in particular thanks to its robust multi-omics patient data exploration capabilities.”
Dr. Ingo Ringshausen
Principal Investigator at University College London & Consultant Haematologist UCLH

“Its ability to rapidly analyze and visualize complex patient data, including spatial omics, delivers insights in moments. It’s a game-changer.”
Pr. Fabrice André
Head of Research Division, Institut Gustave Roussy

“K has the potential to set new standards for efficiency in biomedical research, by streamlining complex data analysis.”
Pr. Franck Bielle
Neuropathologist at APHP, Head of Brain Tumor Heterogeneity Immunity & Therapy research team, Paris Brain Institute

"K makes complex data exploration effortless and enables researchers to efficiently generate new hypotheses."
Pr. Marc Sanson
Head of Neuro Oncology, APHP
Ready to get started?
Discover how K Pro can transform your drug discovery and development. Connect with our team to explore how we can support your specific needs.
*Certain potential users of Owkin K may be subject to anti-gift or anti-bribery regulations based on their profession and jurisdiction. Owkin is collecting all pertinent information from potential users to ensure that anti-gifting and bribery laws are followed across jurisdictions. Owkin reserves the right to restrict access to certain users who are prohibited from accepting them under applicable regulations.













